Skandinaviska Enskilda Banken AB (publ) (STO:SEB.A)
Sweden flag Sweden · Delayed Price · Currency is SEK
168.90
-2.50 (-1.46%)
Aug 1, 2025, 5:29 PM CET

Inozyme Pharma Revenue

Skandinaviska Enskilda Banken AB had revenue of 19.26B SEK in the quarter ending June 30, 2025, a decrease of -4.96%. This brings the company's revenue in the last twelve months to 78.55B, down -3.44% year-over-year. In the year 2024, Skandinaviska Enskilda Banken AB had annual revenue of 81.00B with 2.23% growth.

Revenue (ttm)
78.55B
Revenue Growth
-3.44%
P/S Ratio
4.25
Revenue / Employee
4.13M
Employees
19,000
Market Cap
333.47B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202481.00B1.77B2.23%
Dec 31, 202379.23B16.76B26.83%
Dec 31, 202262.47B7.34B13.32%
Dec 31, 202155.13B11.54B26.46%
Dec 31, 202043.59B-4.25B-8.88%
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Jan 1, 2018 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition